IDEAS home Printed from https://ideas.repec.org/r/eee/respol/v17y1988i3p139-154.html

Bibliometric analysis of U.S. pharmaceutical industry research performance

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. D'Este, Pablo, 2005. "How do firms' knowledge bases affect intra-industry heterogeneity?: An analysis of the Spanish pharmaceutical industry," Research Policy, Elsevier, vol. 34(1), pages 33-45, February.
  2. Stefano Brusoni & Paola Criscuolo & Aldo Geuna, 2005. "The knowledge bases of the world's largest pharmaceutical groups: what do patent citations to non-patent literature reveal?," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 14(5), pages 395-415.
  3. David L. Deeds & Dona Decarolis & Joseph E. Coombs, 1998. "Firm-Specific Resources and Wealth Creation in High-Technology Ventures: Evidence from Newly Public Biotechnology Firms," Entrepreneurship Theory and Practice, , vol. 22(3), pages 55-73, April.
  4. Boyack, Kevin W. & Patek, Michael & Ungar, Lyle H. & Yoon, Patrick & Klavans, Richard, 2014. "Classification of individual articles from all of science by research level," Journal of Informetrics, Elsevier, vol. 8(1), pages 1-12.
  5. Sujit Bhattacharya, 2004. "Mapping inventive activity and technological change through patent analysis: A case study of India and China," Scientometrics, Springer;Akadémiai Kiadó, vol. 61(3), pages 361-381, November.
  6. René Belderbos & Nazareno Braito & Jian Wang, 2024. "Heterogeneous university research and firm R&D location decisions: research orientation, academic quality, and investment type," The Journal of Technology Transfer, Springer, vol. 49(5), pages 1959-1989, October.
  7. Rotolo, Daniele & Camerani, Roberto & Grassano, Nicola & Martin, Ben R., 2022. "Why do firms publish? A systematic literature review and a conceptual framework," Research Policy, Elsevier, vol. 51(10).
  8. Jun Peng Yuan & Wei Ping Yue & Cheng Su & Zheng Wu & Zheng Ma & Yun Tao Pan & Nan Ma & Zhi Yu Hu & Fei Shi & Zheng Lu Yu & Yi Shan Wu, 2010. "Patent activity on water pollution and treatment in China—a scientometric perspective," Scientometrics, Springer;Akadémiai Kiadó, vol. 83(3), pages 639-651, June.
  9. Xin Li & Xuli Tang & Wei Lu, 2023. "Tracking biomedical articles along the translational continuum: a measure based on biomedical knowledge representation," Scientometrics, Springer;Akadémiai Kiadó, vol. 128(2), pages 1295-1319, February.
  10. Cassiman, Bruno & Veugelers, Reinhilde & Zuniga, Pluvia, 2007. "Science linkages and innovation performance: An analysis on CIS-3 firms in Belgium," IESE Research Papers D/671, IESE Business School.
  11. Deeds, David L. & Decarolis, DONA & Coombs, Joseph, 2000. "Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms," Journal of Business Venturing, Elsevier, vol. 15(3), pages 211-229, May.
  12. Godin, Benoit, 1996. "Research and the practice of publication in industries," Research Policy, Elsevier, vol. 25(4), pages 587-606, June.
  13. Deeds, David L. & Decarolis, Dona & Coombs, Joseph E., 1997. "The impact of firmspecific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry," Journal of Business Venturing, Elsevier, vol. 12(1), pages 31-46, January.
  14. Roberto Camerani & Daniele Rotolo & Nicola Grassano, 2018. "Do Firms Publish? A Multi-Sectoral Analysis," SPRU Working Paper Series 2018-21, SPRU - Science Policy Research Unit, University of Sussex Business School.
  15. Geuna, Aldo & Nesta, Lionel J.J., 2006. "University patenting and its effects on academic research: The emerging European evidence," Research Policy, Elsevier, vol. 35(6), pages 790-807, July.
  16. Lee, Mushin & Son, Byoungho & Om, Kiyong, 1996. "Evaluation of national R&D projects in Korea," Research Policy, Elsevier, vol. 25(5), pages 805-818, August.
  17. Li, Xin & Tang, Xuli & Cheng, Qikai, 2022. "Predicting the clinical citation count of biomedical papers using multilayer perceptron neural network," Journal of Informetrics, Elsevier, vol. 16(4).
  18. Anckaert, Paul-Emmanuel, 2025. "When the drugs (don’t) work: The role of science in product commercialization," Research Policy, Elsevier, vol. 54(5).
  19. Dongyu Zang & Chunli Liu, 2023. "Exploring the clinical translation intensity of papers published by the world’s top scientists in basic medicine," Scientometrics, Springer;Akadémiai Kiadó, vol. 128(4), pages 2371-2416, April.
  20. Sternitzke, Christian, 2010. "Knowledge sources, patent protection, and commercialization of pharmaceutical innovations," Research Policy, Elsevier, vol. 39(6), pages 810-821, July.
  21. Anna Giunta & Filippo M. Pericoli & Eleonora Pierucci, 2016. "University–Industry collaboration in the biopharmaceuticals: the Italian case," The Journal of Technology Transfer, Springer, vol. 41(4), pages 818-840, August.
  22. K. Debackere & M. Luwel & Reinhilde Veugelers, 1999. "Can technology lead to a competitive advantage? A case study of Flanders using european patent data," Scientometrics, Springer;Akadémiai Kiadó, vol. 44(3), pages 379-400, March.
  23. Brusoni, Stefano & Geuna, Aldo, 2003. "An international comparison of sectoral knowledge bases: persistence and integration in the pharmaceutical industry," Research Policy, Elsevier, vol. 32(10), pages 1897-1912, December.
  24. Pablo D'Este Cukierman, 2004. "Persistent Knowledge Specialisation and Intra-Industry Heterogeneity: an Analysis of the Spanish Pharmaceutical Industry," SPRU Working Paper Series 110, SPRU - Science Policy Research Unit, University of Sussex Business School.
  25. Anckaert, Paul-Emmanuel & Cassiman, David & Cassiman, Bruno, 2020. "Fostering practice-oriented and use-inspired science in biomedical research," Research Policy, Elsevier, vol. 49(2).
  26. Larsen, Maria Theresa, 2011. "The implications of academic enterprise for public science: An overview of the empirical evidence," Research Policy, Elsevier, vol. 40(1), pages 6-19, February.
  27. Cortés-Sánchez, Julián David, 2019. "Bibliometric outlook of the most cited documents in business, management and accounting in Ibero-America," SocArXiv cqa3z, Center for Open Science.
  28. Eleonora Pierucci, 2015. "University-industry linkages. Among italian regions: a supply-demand analysis," RIVISTA DI ECONOMIA E STATISTICA DEL TERRITORIO, FrancoAngeli Editore, vol. 2015(2), pages 5-33.
  29. Gomez, I. & Fernandez, M. T. & Zulueta, M. A. & Cami, J., 1995. "Analysis of biomedical research in Spain," Research Policy, Elsevier, vol. 24(3), pages 459-471, May.
  30. Rémi Barré & Françoise Laville, 1994. "La bibliométrie des brevets : une mesure de l'activité technologique," Économie et Statistique, Programme National Persée, vol. 275(1), pages 71-81.
  31. Bastian Krieger & Maikel Pellens & Knut Blind & Sonia Gruber & Torben Schubert, 2021. "Are firms withdrawing from basic research? An analysis of firm-level publication behaviour in Germany," Scientometrics, Springer;Akadémiai Kiadó, vol. 126(12), pages 9677-9698, December.
  32. Bastian Rake, 2017. "Determinants of pharmaceutical innovation: the role of technological opportunities revisited," Journal of Evolutionary Economics, Springer, vol. 27(4), pages 691-727, September.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.